Skip to main content

Year: 2020

Acuity Brands, Inc. to Present at the Robert W. Baird 2020 Global Industrial Virtual Conference on November 11, 2020

Atlanta, Nov. 09, 2020 (GLOBE NEWSWIRE) — Acuity Brands, Inc. (NYSE: AYI) (the “Company”) today announced that Neil M. Ashe, President and Chief Executive Officer of Acuity Brands, will present at the Robert W. Baird 2020 Global Industrial Virtual Conference on Wednesday, November 11, 2020.  The presentation will be in the format of a fireside chat and is scheduled to begin at 4:55 p.m. Eastern Time.   A live Webcast of the event will be accessible by clicking here.  This event will also be accessible at the Company’s website www.acuitybrands.com and a replay of this webcast will be available on the company’s website for 90 days following the event.About Acuity BrandsAcuity Brands, Inc. (NYSE: AYI) is a market-leading industrial technology company. We design, manufacture, and bring to market innovative products and services...

Continue reading

Ikänik Farms Signs Surfing Icon Rob Machado to its Action Sports CBD Family

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESVANCOUVER, British Columbia, Nov. 09, 2020 (GLOBE NEWSWIRE) — Canadian Imperial Venture Corp. (TSXV:CQV.H) (the “Company”) announces that Ikänik Farms, Inc.’s (“Ikänik” or “Ikänik Farms”) wholly owned, CBD-focused subsidiary, Ikänik Life, has expanded its action sports family with the signing of surfing icon Rob Machado.Rob is not just one of the world’s greatest surfers, he’s also one of the sport’s most recognizable characters – a living icon who continues to expand the definition and essence of the sport with style, grace, and a zen-like flow on both land and in the water.As a professional competitor, Machado was consistently seeded at the top of the rankings on the ASP World Tour. With 12 career WCT victories, Machado was ranked...

Continue reading

Victory Square Technologies Announces Closing of Upsized and Oversubscribed $6.1 Million Private Placement of Special Warrants Led by Gravitas Securities

/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/VANCOUVER, British Columbia, Nov. 09, 2020 (GLOBE NEWSWIRE) — Victory Square Technologies Inc. (“Victory Square” or the “Company”) (CSE: VST) (OTC: VSQTF) (FWB: 6F6) is pleased to announce that it has completed its previously announced upsized and oversubscribed private placement of special warrants of the Company (“Special Warrants”) for aggregate gross proceeds of approximately $6.1M (the “Offering”). A total of 11,713,053 Special Warrants, including an aggregate of 1,136,129 Special Warrants issued as a result of the exercise of the agent’s over-allotment option pursuant to the Offering, were sold pursuant to the Offering at a price per Special Warrant of $0.52 (the “Offering Price”). The Offering was conducted by Gravitas Securities...

Continue reading

Merus annonce ses résultats financiers pour le troisième trimestre et fait le point sur ses activités

–Mise à jour des données cliniques du programme principal sur le Zenocutuzumab (« Zeno ») prévue pour le 2e trimestre 2021––Arrivée du programme MCLA-129 au stade clinique attendue courant 2021–UTRECHT, Pays-Bas et CAMBRIDGE, Mass., 09 nov. 2020 (GLOBE NEWSWIRE) — Merus N.V. (Nasdaq : MRUS) (la « Société », « nous » ou « notre/nos »), une société d’oncologie au stade clinique qui développe des anticorps multispécifiques de pleine longueur innovants (Biclonics® et TriclonicsTM), a annoncé aujourd’hui ses résultats financiers pour le troisième trimestre clos le 30 septembre 2020 et fait le point sur ses activités.« Notre programme principal sur le Zeno pour le traitement des cancers avec fusion à la neuréguline 1 (NRG1) progresse régulièrement, et nous avons hâte de publier les données de l’essai clinique eNRGy et...

Continue reading

Merus gibt Finanzergebnisse für das dritte Quartal bekannt und legt ein Update zur Geschäftsentwicklung vor

–Update der klinischen Daten und des Programms für den führenden Produktkandidaten Zenocutuzumab („Zeno“) im zweiten Quartal 2021–– Erstmaliger Einsatz von MCLA-129 in der klinischen Praxis voraussichtlich 2021 –UTRECHT, Niederlande, und CAMBRIDGE, Mass., Nov. 09, 2020 (GLOBE NEWSWIRE) — Merus N.V. (Nasdaq: MRUS) („Merus“, „die Gesellschaft“, „wir“ oder „unser“), ein Unternehmen aus dem Bereich der klinischen Onkologie, das innovative multispezifische volllange Antikörper (Biclonics® und Triclonics™) entwickelt, gab heute die Finanzergebnisse für das dritte Quartal zum 30. September 2020 bekannt und legte ein Update zur Geschäftsentwicklung vor.„Unser führender Produktkandidat Zeno für Krebserkrankungen mit Neuregulin-1-Fusionen (NRG1) wird kontinuierlich weiterentwickelt, und wir freuen uns, die Daten aus der klinischen Studie...

Continue reading

CORRECTION: Lilis Energy Announces Ameredev Texas LLC as Winning Bidder for Substantially all of Its Assets in Competitive Auction as Part of Chapter 11 Process

FORT WORTH, Texas, Nov. 09, 2020 (GLOBE NEWSWIRE) — This press release corrects the prior press release dated November 8, 2020 solely with respect to the time and date of the Bankruptcy Court hearing to approve the proposed sale of assets.Lilis Energy, Inc. (OTC: LLEXQ) (the “Company”), an exploration and development company operating in the Permian Basin of West Texas and Southeastern New Mexico, today announced that, following a comprehensive sale process and a competitive auction as part of its Chapter 11 process, Ameredev Texas LLC has been named as the winning bidder to acquire substantially all of the Company’s assets for a $46.6 million cash payment at closing.In accordance with the bidding procedures approved by the United States Bankruptcy Court for the Southern District of Texas, Houston Division (the “Bankruptcy...

Continue reading

Conversion Labs to Host Third Quarter Conference Call on Monday, November 16, 2020 at 4:30 p.m. ET

NEW YORK, Nov. 09, 2020 (GLOBE NEWSWIRE) — Conversion Labs, Inc. (OTCQB: CVLB) (OTCQB: CVLBD), a direct-to-consumer telemedicine and wellness company, will hold a conference call on Monday, November 16, 2020 at 4:30 p.m. Eastern time to discuss its results for the third quarter ended September 30, 2020. The financial results will be issued in a press release prior to the call.Conversion Labs management will host the conference call followed by a question and answer period.Date: Monday, November 16, 2020Time: 4:30 p.m. Eastern time (1:30 p.m. Pacific time)Toll-free dial-in number: 1-800-430-8332International dial-in number: 1-720-452-9103Conference ID: 9683420The conference call will be webcast live and available for replay here as well as via a link in the Investors section of the company’s website at ir.conversionlabs.com.Please...

Continue reading

BJ’s Restaurants, Inc. Appoints Bina Chaurasia to its Board of Directors

HUNTINGTON BEACH, Calif., Nov. 09, 2020 (GLOBE NEWSWIRE) — BJ’s Restaurants, Inc. (NASDAQ: BJRI) today announced the appointment of Ms. Bina Chaurasia to the Company’s Board of Directors as an independent director, effective November 6, 2020. Additionally, Ms. Chaurasia will serve as a member of the Compensation Committee of the Board. The appointment of Ms. Chaurasia brings the total number of the Company’s board members to eleven.Ms. Chaurasia currently serves as the Chief Administrative Officer and Chief People Officer of Tanium, a privately held endpoint security and systems management company based in Emeryville, California, where she is responsible for human resources, global real estate and facilities, and global enablement. Ms. Chaurasia was previously the Chief Human Resources Officer at Ericsson. She joined Ericsson...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.